Real-time enrollment status for this known or highly suspected central nervous system (cns) lesion clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 8:58 PM UTC
| NCT Number | NCT07472491 |
| Recruiting Status | Recruiting |
| Condition | Known or Highly Suspected Central Nervous System (CNS) Lesion |
| Phase | PHASE2 |
| Target Enrollment | 640 participants |
| Active Locations | 2 sites in the US |
| Sponsor | GE Healthcare |
| Last Updated on CT.gov | June 29, 2026 (Jun 29, 2026) |
As of September 2, 2026: Clinical trial NCT07472491 is currently recruiting participants. This phase2 study for known or highly suspected central nervous system (cns) lesion is actively seeking new participants at 2 locations across the United States. The study is sponsored by GE Healthcare. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07472491 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07472491 was last updated Jun 29, 2026 (June 29, 2026). HelloStudys verifies this status automatically.